SXR, a novel steroid and xenobiotic-sensing nuclear receptor.
暂无分享,去创建一个
W. Sabbagh | R. Evans | B. Blumberg | E S Ong | R M Evans | H. Juguilon | J. Bolado | C. M. van Meter | E. Ong | B Blumberg | W Sabbagh | H Juguilon | J Bolado | C M van Meter | R. M. Evans | Casey M. van Meter | Walid Sabbagh
[1] I. Abdu-Aguye,et al. The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine. , 1997, Journal of pharmaceutical and biomedical analysis.
[2] J. Kolars,et al. First-pass metabolism of cyclosporin by the gut , 1991, The Lancet.
[3] R. Evans,et al. Ligation independent cloning irrespective of restriction site compatibility. , 1997, Nucleic acids research.
[4] R. Evans,et al. Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Evans,et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA , 1985, Nature.
[6] K. Umesono,et al. Unique response pathways are established by allosteric interactions among nuclear hormone receptors , 1995, Cell.
[7] S. Matern,et al. Stimulation of bile acid 6 alpha-hydroxylation by rifampin. , 1996, Journal of hepatology.
[8] Peter J. Brown,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .
[9] J. Gustafsson,et al. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] Barry M. Forman,et al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ , 1997 .
[11] F. Gonzalez,et al. Human cytochromes P450: problems and prospects. , 1992, Trends in pharmacological sciences.
[12] K. Umesono,et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. , 1995, Genes & development.
[13] D. Moore,et al. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements , 1994, Molecular and cellular biology.
[14] Jameyla A. Ladias,et al. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily , 1991, Science.
[15] K. Stringer,et al. Enhanced Pirmenol Elimination by Rifampin , 1988, Journal of clinical pharmacology.
[16] G. Reimondo,et al. Misdiagnosis of Cushing's syndrome in a patient receiving rifampicin therapy for tuberculosis. , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[17] K. Umesono,et al. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors , 1991, Cell.
[18] P. Watkins,et al. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[19] V. Kyriazopoulou,et al. Rifampicin-induced adrenal crisis in addisonian patients receiving corticosteroid replacement therapy. , 1984, The Journal of clinical endocrinology and metabolism.
[20] J. Lehmann,et al. An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.
[21] Joseph L. Napoli,et al. Vitamin D Metabolism , 1984 .
[22] E. C. Dodds. Hormones. , 1946, Health education journal.
[23] F. Guengerich. Metabolism of 17 α-ethynylestradiol in humans , 1990 .
[24] Rodger Staden,et al. The current status and portability of our sequence handling software , 1986, Nucleic Acids Res..
[25] T. H. Zawawi,et al. The effects of therapy with rifampicin and isoniazid on basic investigations for Cushing’s syndrome , 1996, Irish journal of medical science.
[26] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[27] S. Matern,et al. Stimulation of bile acid 6α-hydroxylation by rifampin , 1996 .
[28] K. Umesono,et al. BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites. , 1998, Genes & development.
[29] Miguel Beato,et al. Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.
[30] P. Beaune,et al. Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[31] O. M. Edwards,et al. Changes in cortisol metabolism following rifampicin therapy. , 1974, Lancet.
[32] J. Kolars,et al. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. , 1992, The Journal of clinical investigation.
[33] H. Selye. Hormones and resistance. , 1970, Journal of pharmaceutical sciences.
[34] G. Wilkinson,et al. Induction of propranolol metabolism by rifampicin. , 1983, British journal of clinical pharmacology.
[35] J. Devereux,et al. A comprehensive set of sequence analysis programs for the VAX , 1984, Nucleic Acids Res..
[36] P. Lønning,et al. Plasma levels of estradiol, estrone, estrone sulfate and sex hormone binding globulin in patients receiving rifampicin. , 1989, Journal of steroid biochemistry.
[37] E. Schuetz,et al. Paradoxical transcriptional activation of rat liver cytochrome P-450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16 alpha-carbonitrile: analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[38] R. Tukey,et al. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. , 1996, Molecular pharmacology.
[39] K. Umesono,et al. Determinants for selective RAR and TR recognition of direct repeat HREs. , 1993, Genes & development.
[40] F. Guengerich. Metabolism of 17 alpha-ethynylestradiol in humans. , 1990, Life sciences.
[41] R. Evans,et al. A retinoic acid-triggered cascade of HOXB1 gene activation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[42] G. Kondos,et al. Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlates. , 1988, Chest.
[43] William Bourguet,et al. A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.
[44] J. Idle,et al. The role of individual human cytochromes P450 in drug metabolism and clinical response. , 1992, Trends in pharmacological sciences.
[45] E. Schuetz,et al. Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism. , 1984, The Journal of biological chemistry.
[46] Slobodan Petar Rendic,et al. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. , 1997, Drug metabolism reviews.
[47] O. Hankinson. The aryl hydrocarbon receptor complex. , 1995, Annual review of pharmacology and toxicology.
[48] P. Thompson,et al. Rifampicin reduces effectiveness and bioavailability of prednisolone. , 1983, British medical journal.
[49] M. Baker. Endocrine Activity of Plant-Derived Compounds: An Evolutionary Perspective , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[50] P. Fernández-Salguero,et al. The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis. , 1995, Pharmacogenetics.
[51] M. Denison,et al. Xenobiotic-inducible Transcription of Cytochrome P450 Genes (*) , 1995, The Journal of Biological Chemistry.
[52] R. Evans,et al. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor , 1987, Cell.
[53] D. Nebert,et al. Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation , 1986, Molecular and cellular biology.
[54] M. Fromm,et al. The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[55] J. D. Wilson,et al. Steroid 5 alpha-reductase: two genes/two enzymes. , 1994, Annual review of biochemistry.
[56] J. Lehmann,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[58] V. Kyriazopoulou,et al. Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy. , 1992, The Journal of clinical endocrinology and metabolism.
[59] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.